Securing and streamlining the clinical trial process will make for better outcomes for patients.
SHARE
42
4
Featuring Raymond van der Waal, Hadil-Es-Sbai and Santiago Velez
Mar 21, 2022 • 48 minutes
Clinical trials are a crucial part of the development of new medicines. But existing processes are antiquated, and it can take as many as 10 years before a new drug is approved. As demonstrated during the response to the COVID-19 pandemic, efficient influx of vaccines and other innovative solutions is critical for society’s current and future medical needs. Triall is leading the deployment of blockchain-integrated software solutions to accelerate delivery of new drugs to patients. Triall co-founder and CEO Hadil Es-Sbai and co-founder and head of marketing Raymond van der Waal join Santiago Velez, co-founder and division lead of R&D at Block Digital, to talk about the world’s first digital ecosystem for clinical trials and how it will improve reliability and efficiency in the drug-development process. Recorded on March 7, 2022.
Show MoreIn the fast-moving world of cryptocurrency, Real Vision CRYPTOVERSE works at an accelerated pace to keep you ahead of market swings and ever-evolving innovations. Crypto's smartest minds sit down for in-depth discussions covering everything from the blockchain and DeFi to NFTs, Web 3.0., the Metaverse, and what's still beyond the visible horizon.
More EpisodesIn the fast-moving world of cryptocurrency, Real Vision CRYPTOVERSE works at an accelerated pace to keep you ahead of market swings and ever-evolving innovations. Crypto's smartest minds sit down for in-depth discussions covering everything from the blockchain and DeFi to NFTs, Web 3.0., the Metaverse, and what's still beyond the visible horizon.
More Episodes
COMMENTS
Sort ByAccess Crypto Content
This content is reserved for the thousands of visionaries supporting the financial revolution. We'd love for you to join us. Interested?
Join NowAlready have an account? Log In